Entrada Therapeutics

Biotechnology

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.

TRDA

Visualizar Fundamentos

Entrada Therapeutics

1,8

P/B

3,4

P/S

—

P/EBITDA

3,1

P/OCF

3,2

P/FCF

—

Forward P/E

7,2

BVPS

—

EPS